Chitosan-based nanoparticles fabricated by ionotropic gelation using two types of polyphosphates: characterization and in-vitro release modeling of curcumin

Abstract

Aim: Chitosan (CHS)-based nanoparticulate systems have gained much interest due to their high drug loading capacity and the simplicity of their fabrication. The physical properties of two types of curcumin-loaded CHS nanoparticles (CHS-NPs) were determined and compared. A new in-vitro release method was developed based on mathematical modeling in which the drug is first released from the NP into the surrounding medium and subsequently diffuses through the membrane.

Methods: Curcumin-loaded CHS-NPs were fabricated by ionotropic gelation using sodium tripolyphosphate (TPP) and sodium hexametaphosphate (SHMP) crosslinking, and characterized by NP tracking analysis, loading capacity, zeta potential, Fourier transform infrared spectroscopy (FTIR), and in-vitro release rates.

Results: The data showed that compared to SHMP crosslinked CHS-NPs, TPP crosslinking demonstrated a decrease in entrapment efficiency at a relatively high concentration of the agent, probably by narrowing the space between the polymeric chains. As indicated by zeta potential measurements, TPP crosslinking at all levels was more uniformly distributed inside the NPs, whereas the higher molecular weight SHMP at a low concentration creates NPs mostly by binding onto the surface. It was found that the release rates of curcumin from CHS-NPs crosslinked by SHMP at higher concentrations were about twice as high as the release rates of curcumin from TPP-crosslinked CHS-NPs, accompanied by notable lag times.

Conclusions: This significant increase in the release rates of curcumin from SHMP-crosslinked CHS-NPs is explained by the large spatial structure of this crosslinker compared to the small TPP molecules. This study advances the literature on drug diffusion by making it possible to accurately determine its release from nanoparticulate systems.

Keywords

chitosan nanoparticles / curcumin / tripolyphosphate / sodium hexametaphosphate / in-vitro release

References

[1] das Neves J, Bahia MF, Amiji MM, Sarmento B. Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale. Expert Opin Drug Deliv. 2011; 8: 1085-104.

[2] Hasnain MS, Nayak AK. Chitosan as mucoadhesive polymer in drug delivery. In: Hasnain MS, Beg S, editors. Chitosan in Drug Delivery. Elsevier; 2022. pp. 225-46.

[3] Ahmad K, Zhang Y, Chen P, Yang X, Hou H. Chitosan interaction with stomach mucin layer to enhances gastric retention and mucoadhesive properties. Carbohydr Polym. 2024; 333: 121926.

[4] Shariatinia Z. Pharmaceutical applications of chitosan. Adv Colloid Interface Sci. 2019; 263: 131-94.

[5] Panda PK, Sadeghi K, Park K, Seo J. Regeneration Approach to Enhance the Antimicrobial and Antioxidant Activities of Chitosan for Biomedical Applications. Polymers (Basel). 2022; 15: 132.

[6] Zhang X, Liang Y, Huang S, Guo B. Chitosan—based self—healing hydrogel dressing for wound healing. Adv Colloid Interface Sci. 2024; 332: 103267.

[7] Jafernik K, Ładniak A, Blicharska E, Czarnek K, Ekiert H, Wiącek AE, et al. Chitosan—Based Nanoparticles as Effective Drug Delivery Systems—A review. Molecules. 2023; 28: 1963.

[8] Jha R, Mayanovic RA. A Review of the Preparation, Characterization, and Applications of Chitosan Nanoparticles in Nanomedicine. Nanomaterials (Basel). 2023; 13: 1302.

[9] Bashir SM, Ahmed Rather G, Patrício A, Haq Z, Sheikh AA, Shah MZUH, et al. Chitosan Nanoparticles: A Versatile Platform for Biomedical Applications. Materials (Basel). 2022; 15: 6521.

[10] Luppi B, Bigucci F, Cerchiara T, Zecchi V. Chitosan—based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin Drug Deliv. 2010; 7: 811-28.

[11] Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. J Control Release. 2022; 351: 923—40.

[12] Baek JS, Cho CW. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur J Pharm Biopharm. 2017; 117: 132—40.

[13] Grenha A. Chitosan nanoparticles: a survey of preparation methods. J Drug Target. 2012; 20: 291-300.

[14] Yanat M, Schroën K. Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging. React Funct Polym. 2021; 161: 104849.

[15] Tian XX, Groves MJ. Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles. J Pharm Pharmacol. 1999; 51: 151-7.

[16] Zoe LH, David SR, Rajabalaya R. Chitosan nanoparticle toxicity: A comprehensive literature review of in vivo and in vitro assessments for medical applications. Toxicol Rep. 2023; 11: 83-106.

[17] Aibani N, Rai R, Patel P, Cuddihy G, Wasan EK. Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery. Pharmaceutics. 2021; 13: 1686.

[18] Jhaveri J, Raichura Z, Khan T, Momin M, Omri A. Chitosan Nanoparticles—Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics. Molecules. 2021; 26: 272.

[19] Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 2007; 24: 2198-206.

[20] Calvo P, Remuñán—López C, Vila—Jato JL, Alonso MJ. Novel hydrophilic chitosan—polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997; 63: 125-32.

[21] Sang Z, Qian J, Han J, Deng X, Shen J, Li G, et al. Comparison of three water—soluble polyphosphate tripolyphosphate, phytic acid, and sodium hexametaphosphate as crosslinking agents in chitosan nanoparticle formulation. Carbohydr Polym. 2020; 230: 115577.

[22] Saeed RM, Dmour I, Taha MO. Stable Chitosan—Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles for Drug Delivery. Front Bioeng Biotechnol. 2020; 8: 4.

[23] Thandapani G, P SP, P N S, Sukumaran A. Size optimization and in vitro biocompatibility studies of chitosan nanoparticles. Int J Biol Macromol. 2017; 104: 1794-806.

[24] Hu Q, Luo Y. Chitosan—based nanocarriers for encapsulation and delivery of curcumin: A review. Int J Biol Macromol. 2021; 179: 125-35.

[25] Yu Y, Shen Q, Lai Y, Park SY, Ou X, Lin D, et al. Anti—inflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol. 2018; 9: 386.

[26] Yu X, Chen L, Tang M, Yang Z, Fu A, Wang Z, et al. Revealing the Effects of Curcumin on SH—SY5Y Neuronal Cells: A Combined Study from Cellular Viability, Morphology, and Biomechanics. J Agric Food Chem. 2019; 67: 4273—9.

[27] Liu S, Liu J, He L, Liu L, Cheng B, Zhou F, et al. A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health. Molecules. 2022; 27: 4400.

[28] Quispe C, Herrera—Bravo J, Javed Z, Khan K, Raza S, Gulsunoglu—Konuskan Z, et al. Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective. Biomed Res Int. 2022; 2022: 1375892.

[29] Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr. 2020; 60: 887-939.

[30] Xu H, Ma Q, Qiu C, Wang J, Jin Z, Hu Y. Encapsulation and controlled delivery of curcumin by self—assembled cyclodextrin succinate/chitosan nanoparticles. Food Hydrocolloids. 2024; 157: 110465.

[31] Mishra B, Yadav AS, Malhotra D, Mitra T, Sinsinwar S, Radharani NNV, et al. Chitosan Nanoparticle—Mediated Delivery of Curcumin Suppresses Tumor Growth in Breast Cancer. Nanomaterials (Basel). 2024; 14: 1294.

[32] Diaz—Ramirez J, Basasoro S, Torresi S, Eceiza A, Retegi A, Gabilondo N. Bacterial cellulose/thiolated chitosan nanoparticles hybrid antimicrobial dressing for curcumin delivery. Int J Biol Macromol. 2025; 289: 138836.

[33] Rezagholizade—shirvan A, Masrournia M, Fathi Najafi M, Behmadi H. Synthesis and characterization of nanoparticles based on chitosan—biopolymers systems as nanocarrier agents for curcumin: study on pharmaceutical and environmental applications. Polym Bull. 2022; 80: 1495-517.

[34] Ray L, Pal MK, Ray RS. Synergism of co—delivered nanosized antioxidants displayed enhanced anticancer efficacy in human colon cancer cell lines. Bioact Mater. 2017; 2: 82-95.

[35] Sintov AC, Enden G. New doxorubicin nanoparticles engineered from calcium—crosslinked carbomer and a microemulsion precursor. Drug Dev Ind Pharm. 2017; 43: 830-8.

[36] Sintov AC. Nanoparticulate System Based on Calcium—Crosslinked Carbomer Retards Percutaneous Drug Permeation: New Insight Into Skin Barrier Functions. Pharm Res. 2022; 39: 3331-43.

[37] Algharib SA, Dawood A, Zhou K, Chen D, Li C, Meng K, et al. Preparation of chitosan nanoparticles by ionotropic gelation technique: Effects of formulation parameters and in vitro characterization. J Mol Struct. 2022; 1252: 132129.

[38] Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release. 2001; 73: 255-67.

[39] Hoang NH, Le Thanh T, Sangpueak R, Treekoon J, Saengchan C, Thepbandit W, et al. Chitosan Nanoparticles—Based Ionic Gelation Method: A Promising Candidate for Plant Disease Management. Polymers (Basel). 2022; 14: 662.

[40] Muzzarelli RA. Genipin—crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohydr Polym. 2009; 77: 1-9.

[41] Divya K, Jisha MS. Chitosan nanoparticles preparation and applications. Environ Chem Lett. 2017; 16: 101—12.

[42] Ukwubile CA, Otalu O, Okoro RN, Paul S. Antibacterial and anticancer synergy of chitosan NPs loaded with Curcuma longa (turmeric) extract against Helicobacter pylori—associated AGS gastric cancer cells. J Res Complement Med. 2025; 2: 59-69.

[43] Nair RS, Morris A, Billa N, Leong CO. An Evaluation of Curcumin—Encapsulated Chitosan Nanoparticles for Transdermal Delivery. AAPS PharmSciTech. 2019; 20: 69.

[44] Asif HM, Zafar F, Ahmad K, Iqbal A, Shaheen G, Ansari KA, et al. Synthesis, characterization and evaluation of anti—arthritic and anti—inflammatory potential of curcumin loaded chitosan nanoparticles. Sci Rep. 2023; 13: 10274.

[45] Gupta PK, Hung CT, Perrier DG. Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci. 1987; 76: 141—5.

[46] Abdelgawad AM, Hudson SM. Chitosan nanoparticles: Polyphosphates cross—linking and protein delivery properties. Int J Biol Macromol. 2019; 136: 133—42.

[47] Cervera MF, Heinämäki J, de la Paz N, López O, Maunu SL, Virtanen T, et al. Effects of spray drying on physicochemical properties of chitosan acid salts. AAPS PharmSciTech. 2011; 12: 637—49.

[48] Bhumkar DR, Pokharkar VB. Studies on effect of pH on cross—linking of chitosan with sodium tripolyphosphate: a technical note. AAPS PharmSciTech. 2006; 7: E50.

[49] Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan—based nanoparticles. Heliyon. 2021; 8: e08674.

[50] Gomathi T, Alam MM, Al—Sehemi AG, Sudha PN, Pazhanisamy P, Vijayakumar S. Evaluation of sustained release and cytotoxicity studies of 5—fluorouracil loaded chitosan nanoparticles using sodium tripolyphosphate/sodium hexametaphosphate. Biomass Conv Bioref. 2024; 15: 26653-73.

[51] Warsito MF, Agustiani F. A review on factors affecting chitosan nanoparticles formation. IOP Conf Ser Mater Sci Eng. 2021; 1011: 012027.

[52] Rostami E. Progresses in targeted drug delivery systems using chitosan nanoparticles in cancer therapy: A mini—review. J Drug Deliv Sci Technol. 2020; 58: 101813.